Related Experiment Videos

[Present status of radiotherapy]

F Mornex¹, J Mazeron

¹Département de radiothérapie, centre Léon-Bérard, Lyon, France.

Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique

|January 1, 1990

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.

ESMO open·2026

Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R.

ESMO open·2024

Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022

Radiotherapy for patient with cardiac implantable electronic device, consensus from French radiation oncology society.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021

Radiation therapy of pancreatic cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021

See all related articles